Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer

Prostate‐specific antigen nadir (nPSA) after radiotherapy for localized prostate cancer has been investigated as a predictor. However, nPSA usually requires several years, limiting its clinical utility. We investigated the significance of nPSA within 12 months (nPSA12) after low‐dose‐rate prostate b...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Nishimura, Shuichi, Ohashi, Toshio, Momma, Tetsuo, Sakayori, Masanori, Eriguchi, Takahisa, Tanaka, Tomoki, Yamashita, Shoji, Kosaka, Takeo, Oya, Mototsugu, Shigematsu, Naoyuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943430/
https://ncbi.nlm.nih.gov/pubmed/29577651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1443
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi